Sanjay Srivastava Selected Research

sorbinil

4/2008	Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.
8/2002	Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sanjay Srivastava Research Topics

Disease

20	Inflammation (Inflammations) 02/2022 - 11/2004
14	Atherosclerosis 02/2022 - 02/2003
14	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 04/2007
4	Insulin Resistance 01/2019 - 01/2019
3	Hypertrophy 11/2011 - 06/2007
3	Dyslipidemias (Dyslipidemia) 09/2011 - 02/2010
3	Hyperglycemia 05/2011 - 02/2003
3	Diabetes Complications 11/2004 - 02/2003
2	Glucose Intolerance 02/2022 - 01/2019
2	Pneumonia (Pneumonitis) 02/2022 - 10/2010
2	Heart Failure 12/2021 - 11/2011
2	Neoplasms (Cancer) 01/2021 - 02/2009
2	Hyperemia 01/2021 - 01/2019
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020 - 01/2019
2	Disease Progression 01/2019 - 02/2009
2	Peritonitis 02/2016 - 01/2015
2	Lung Neoplasms (Lung Cancer) 01/2016 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2015
2	Carcinogenesis 01/2016 - 01/2015
2	Ischemia 08/2015 - 04/2008
2	Necrosis 05/2015 - 03/2012
2	Fibrosis (Cirrhosis) 05/2010 - 04/2006
2	Infarction (Infarctions) 04/2008 - 08/2002
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Fatty Liver 12/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Abnormal Reflex (Hyperreflexia) 01/2021
1	Human Influenza (Influenza) 10/2019
1	Severe Acute Respiratory Syndrome 10/2019
1	COVID-19 10/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Alcoholic Hepatitis 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 01/2019
1	End Stage Liver Disease 01/2019
1	Myocardial Infarction 12/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2018

Drug/Important Bio-Agent (IBA)

13	Acrolein (Aqualin)IBA 01/2021 - 08/2003
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2006
8	AldehydesIBA 08/2015 - 12/2004
5	Biomarkers (Surrogate Marker)IBA 02/2022 - 12/2018
5	CytokinesIBA 02/2022 - 02/2003
5	Aldehyde Reductase (Aldose Reductase)IBA 03/2021 - 02/2003
5	Apolipoproteins E (ApoE)IBA 01/2019 - 04/2007
4	Benzene (Benzole)IBA 12/2021 - 01/2017
4	Lipoproteins (Lipoprotein)IBA 01/2019 - 02/2010
4	LipidsIBA 01/2019 - 10/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2003
4	SmokeIBA 01/2019 - 04/2011
3	Nicotine FDA Link 01/2019 - 01/2019
3	ApolipoproteinsIBA 05/2017 - 02/2009
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2015
3	ArsenicIBA 11/2009 - 04/2007
3	tolrestatIBA 04/2008 - 08/2002
3	polyolIBA 11/2004 - 02/2003
2	LDL Receptors (LDL Receptor)IBA 02/2022 - 05/2017
2	fidarestatIBA 03/2021 - 05/2011
2	CatecholaminesIBA 01/2021 - 12/2007
2	epsinIBA 01/2020 - 01/2019
2	Insulin (Novolin)FDA Link 01/2019 - 04/2008
2	Drinking WaterIBA 01/2019 - 04/2007
2	CholesterolIBA 05/2017 - 02/2010
2	Triglycerides (Triacylglycerol)IBA 09/2011 - 02/2010
2	Streptozocin (Streptozotocin)FDA Link 05/2011 - 04/2006
2	Malondialdehyde (Propanedial)IBA 05/2010 - 06/2007
2	EnzymesIBA 02/2010 - 03/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 02/2003
2	sorbinilIBA 04/2008 - 08/2002
2	Sorbitol (Yal)FDA Link 04/2008 - 08/2002
2	2-nonenalIBA 04/2006 - 08/2002
2	Transcription Factors (Transcription Factor)IBA 11/2004 - 08/2002
2	NF-kappa B (NF-kB)IBA 11/2004 - 08/2002
1	Volatile Organic CompoundsIBA 12/2021
1	Cell Adhesion MoleculesIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	AnthracyclinesIBA 03/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021
1	1,3-butadiene (divinyl)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Biological ProductsIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	tributyrinIBA 01/2020
1	Butyrates (Butyrate)IBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2019
1	tempolIBA 01/2019
1	hydroxypropyl methacrylateIBA 01/2019
1	AcetaldehydeIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	S-(3-hydroxypropyl)cysteine N-acetateIBA 01/2019
1	Lobeline (Smokeless)IBA 01/2019
1	Organic Chemicals (Chemicals, Organic)IBA 01/2019
1	Superoxide DismutaseIBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2018
1	Biogenic MonoaminesIBA 11/2018

Therapy/Procedure

3	Therapeutics 02/2016 - 05/2011
3	Ligation 02/2016 - 04/2008
1	Drug Therapy (Chemotherapy) 03/2021
1	Intravenous Administration 01/2021
1	Traditional Medicine (Folk Remedies) 10/2019